window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 24, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Delivery & Formulation

  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Delivery & Formulation,Partnerships & Funding,Technology and platforms

    LNP pioneer Pieter Cullis joins Hongene’s scientific advisory board

    Hongene has appointed leading lipid nanoparticle (LNP) researcher Pieter Cullis [...]

    August 5, 2025
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Movers & Shakers,Oncology,Precision medicine

    PhoreMost appoints Pfizer drug discovery veteran Dr Adam Gilbert to scientific advisory board

    Appointment strengthens expertise in targeted protein degradation as company advances [...]

    July 28, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Global health,Movers & Shakers,Supply Chain & Logistics,Technology and platforms

    Colorcon expands global supply network with new pharmaceutical film coating facility in Malaysia

    Colorcon has officially opened a new pharmaceutical film coating manufacturing [...]

    July 25, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Delivery & Formulation,Partnerships & Funding

    Stevanato Group secures €200 million to support global capacity expansion for drug delivery solutions

    Stevanato Group has secured €200 million in financing to support [...]

    July 30, 2025
  • Biologics & Biosimilars,Clinical Development,Drug Delivery & Formulation,Global health,Partnerships & Funding,Rare Diseases

    New research partnership targets $1 malaria prevention shot using next-gen biologics

    Eyam Health, a Canadian biotech, teams with Medicines for Malaria [...]

    July 22, 2025
  • Drug Delivery & Formulation,Patient Centricity,Regulatory Affairs

    NICE recommends first immunotherapy tablet targeting root cause of tree pollen hay fever

    The National Institute for Health and Care Excellence (NICE) has [...]

    July 22, 2025
  • Drug Delivery & Formulation,Regulatory Affairs,Supply Chain & Logistics

    From clinical waste to carbon cuts: The firm helping pharma go green

    A Yorkshire-based company is quietly transforming how pharmaceutical and clinical [...]

    July 18, 2025
  • Clinical Development,Drug Delivery & Formulation,Drug Development,Medical devices,Regulatory Affairs

    MHRA approval expected soon for non-surgical weight loss device RESET

    Morphic Medical’s non-invasive weight loss device RESET is expected to [...]

    July 18, 2025
  • Drug Delivery & Formulation,Precision medicine,Technology and platforms

    Pusan National University researchers develop UV-activated smart materials for reversible shape-shifting and fixing

    Researchers at Pusan National University in South Korea have created [...]

    July 16, 2025
  • Drug Delivery & Formulation,Drug Development,Patient Centricity

    Most people with HIV choose long-acting injectables over daily pills

    Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]

    July 15, 2025
Previous345Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Currax highlights peer-reviewed review supporting combination approaches in obesity treatment
    Categories: Obesity, Pharmaceuticals and therapeutics, Research & Development
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top